WHO ICTRP trial
Radium-223 Dichloride in the treatment of patients diagnosed with prostate…
EUCTR2012-000075-16-SE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2012-000075-16-SE |
|---|---|
| Public title | Radium-223 Dichloride in the treatment of patients diagnosed with prostate cancer that has spread to the bone |
| Scientific title | Radium-223 Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients with Bone Metastasis - Radium-223 dichloride in the treatment of CRPC/HRPC patients with bone metastasis |
| Primary sponsor | Bayer HealthCare AG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Finland;Spain;Ireland;Austria;Russian Federation;Israel;Italy;Switzerland;United Kingdom;Czech Republic;Mexico;Canada;Poland;Belgium;Denmark;Norway;Netherlands;Germany;Sweden |
| Conditions | Castrate Resistant Prostate Cancer/Hormone-Refractory Prostate Cancer patients with bone metastasis MedDRA version: 18.1 Level: LLT Classification code 10036916 Term: Prostate cancer stage D System Organ Class: 100000004864 ;Therapeutic… |
| Interventions | Product Name: Radium-223 dichloride Product Code: BAY88-8223 Pharmaceutical Form: Solution for injection INN or Proposed INN: Radium-223 dichloride CAS Number: 444811-40-9 Current Sponsor code: BAY88-8223 Concentration unit: kBq/ml… |
| Registration date | Mar 28, 2012 |
| Target size | 1500 |
| Secondary IDs | BAY88-8223/16216 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: